Daunorubicin

Daunorubicin, also known as doxorubicin, is a chemotherapy drug. Has antitumor effect. It is used for acute leukemia, as well as in the treatment of tumors of the ovaries, breast, kidneys, bladder, larynx, esophagus and other organs.

Daunorubicin is an antibiotic that affects DNA synthesis, making it effective in the treatment of acute leukemia. It is given by injection and can cause side effects such as hair loss, bone marrow and heart damage, which can be serious and require medical attention. However, daunorubicin remains one of the most effective drugs to combat blood cancer and other diseases.

Daunorubicin is an antibiotic used to treat acute lymphoblastic leukemia in children and adults. It works by inhibiting DNA synthesis in tumor cells, leading to their death.

Daunorubicin is available as an injection, which is given intravenously or intramuscularly. It is usually used in combination with other drugs such as asparaginase, cyclophosphamide and vincristine.

One of the side effects of daunorubicin is hair loss. This may happen within a few months of starting treatment. Damage to the bone marrow and myocardium is also possible, which can lead to anemia, leukopenia and heart failure.

Despite the side effects, daunorubicin remains one of the most effective drugs for the treatment of lymphoblastic leukemia. It allows many patients to achieve remission and improve their quality of life.

Daunorubinosin or Doxorubinovin (Dunomycin, Doxirubicin) is a drug that shows a positive effect in the treatment of many diseases, especially blood diseases.

Composition The drug is a complex of proteins obtained from the Streptomyces rubescens strain, one of the most dangerous types of bacteria. Sometimes it is also called a semi-synthetic antibiotic. Medicinal properties: * inhibits protein synthesis, especially in malignant cells in the M phase * causes inhibition of mitosis of malignant cells * exhibits doxorubicin activity at all stages of the tumor process, but is most effective in leukemia and some lymphomas * Dauno rubicin can accelerate hair growth, quantity enzymes produced by the thyroid gland, which reduces the risk of developing thyrotoxicosis. Application The drug is prescribed taking into account the patient’s age, the direction of therapy and the severity of the disease. Most often, tablets or injections are prescribed by a medical oncology specialist. Often, after a relapse is detected, there is a need for a second course of therapy. Despite the fact that therapy lasts for 4-6 months after the relief of primary acute leukemia, the course of treatment is extended for another six months, then reinduction is carried out. Diseases requiring prescription: - Acute myeloid and B-cell chronic disease; - Acute lymphoblastic leukemia; - Metastases